Profil
Deniz Kural is the founder of Seven Bridges Genomics, Inc., which was founded in 2009.
He held the title of Executive Chairman from 2017 to 2018.
Dr. Kural is also the founder of Totient, Inc., which was founded in 2017.
He currently holds the title of Chief Executive Officer at Totient, Inc.
Postes actifs de Deniz Kural
| Sociétés | Poste | Début |
|---|---|---|
Totient, Inc.
 Totient, Inc. Pharmaceuticals: MajorHealth Technology Totient, Inc. provides biotechnology services. The company was founded by Deniz Kural and is headquartered in Cambridge, MA. | Directeur Général | - |
Anciens postes connus de Deniz Kural
| Sociétés | Poste | Fin |
|---|---|---|
Seven Bridges Genomics, Inc.
 Seven Bridges Genomics, Inc. Packaged SoftwareTechnology Services Seven Bridges Genomics, Inc. operates as a biomedical data analysis company. It offers genomics research for cancer, drug development and precision medicine. The company was founded by Deniz Kural, Igor Bogicevic and John Sheffield in 2009 and is headquartered in San Francisco, CA. | Directeur Général | 16/03/2017 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Seven Bridges Genomics, Inc.
Seven Bridges Genomics, Inc. Packaged SoftwareTechnology Services Seven Bridges Genomics, Inc. operates as a biomedical data analysis company. It offers genomics research for cancer, drug development and precision medicine. The company was founded by Deniz Kural, Igor Bogicevic and John Sheffield in 2009 and is headquartered in San Francisco, CA. | Technology Services |
Totient, Inc.
Totient, Inc. Pharmaceuticals: MajorHealth Technology Totient, Inc. provides biotechnology services. The company was founded by Deniz Kural and is headquartered in Cambridge, MA. | Health Technology |
